Michael J. Boskin - May 7, 2024 Form 4 Insider Report for ORACLE CORP (ORCL)

Role
Director
Signature
/s/ Aimee Weast by Aimee Weast, Attorney in Fact for Michael J. Boskin (POA filed 6/4/19)
Stock symbol
ORCL
Transactions as of
May 7, 2024
Transactions value $
-$3,341,147
Form type
4
Date filed
5/8/2024, 05:19 PM
Previous filing
Jun 23, 2023
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORCL Common Stock Options Exercise $1.96M +45K +51.44% $43.49 132K May 7, 2024 Direct
transaction ORCL Common Stock Sale -$5.3M -45K -33.97% $117.74 87.5K May 7, 2024 Direct F1, F2
holding ORCL Common Stock 1K May 7, 2024 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORCL Stock Option Options Exercise $0 -45K -100% $0.00* 0 May 7, 2024 Common Stock 45K $43.49 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale of shares pursuant to a Rule 10b5-1 plan adopted on February 6, 2024.
F2 This transaction was executed in multiple trades at prices ranging from $117.32 to $118.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
F3 25% of the shares subject to the option vested annually on each anniversary of the grant date.